Several foam manufacturers have agreed to pay $30 million to settle lawsuits filed by the families of the 100 people killed in a nightclub fire in Rhode Island, pushing the total value of the settlements from the blaze to more than $100 million.
A federal district judge has bounced a lawsuit brought by food giant Solae Inc. as it continues to trade barbs with Hershey Canada over liability for a salmonella-tainted additive that found its way into a sundae product.
Following in the footsteps of Medtronic Inc., Atrium Medical Corporation has decided to recall a heparin-coated product as the fallout from tainted batches of the blood thinner continues.
The government has weighed in on Pfizer Inc.'s bid to dismiss a whistleblower lawsuit filed by a former executive alleging that the company illegally marketed human growth hormone Genotropin.
The U.S. Supreme Court has brought an end to a proposed antitrust class action claiming the 1998 master settlement agreement created between tobacco companies and states allowed cigarette manufacturers to establish an illegal price-fixing scheme.
Five Dallas-based partners from some of the largest law firms in the United States have joined together to create a majority women-owned firm that will specialize in labor and employment law, litigation, business immigration and dispute resolution.
A group of plaintiffs' attorneys in the Zyprexa multidistrict litigation has objected to a magistrate judge's ruling rejecting its attempt to secure additional fees and has asked the court to award it $3.8 million.
A group of companies that produce gadolinium-based injectable contrast agents has been hit with yet another product liability lawsuit, this time by a patient whose legs had to be amputated when she developed nephrogenic systemic fibrosis after being exposed to the dye during magnetic resonance imaging procedures.
A $400 billion lawsuit against 32 corporate giants — including Bank of America NA, ChevronTexaco Corp., Dow Chemical Co. and IBM Corp. — for allegedly helping the South African government continue its apartheid policies can move forward because the U.S. Supreme Court lacked a quorum to review a circuit court decision.
Bankrupt vitamin producer Leiner Health Products Inc. has reached a tentative settlement with U.S. investigators over alleged deficiencies in the over-the-counter drugs manufactured at the company's South Carolina plant.
The U.S. Supreme Court and other appellate courts have regularly reduced punitive damage awards that have been deemed unconstitutional for violating defendant due process rights. However, large damage awards have continued to be doled out, leading defense attorneys to urge clearer standards and greater scrutiny for such verdicts in order to avoid a “punishment lottery.”
The Bush administration is trying to stop a private meatpacker from voluntarily testing its supply of cattle for mad cow disease, arguing that the extra measures could be misleading to consumers since they don't necessarily guarantee safer food.
A special master in the Bausch & Lomb Inc. contact-solution multidistrict litigation has told the company to turn over documents it had argued were protected by attorney-client privilege.
The Arkansas Supreme Court has ruled that fumes from arsenic-laden chicken litter likely caused a man to develop a rare form of leukemia and has remanded the case for trial.
The chairman of the congressional committee investigating the fatal August 2007 collapse at Utah's Crandall Canyon Mine has blamed owner Murray Energy Corp. for submitting a "flawed" plan and the U.S. Mine Safety and Health Administration for approving it.
State Farm Fire and Casualty Co. has reached out-of-court settlements with several policyholders who sued the insurance company in the wake of Hurricane Katrina even though the plaintiffs’ attorneys were disqualified by a federal judge last month.
Studies by U.S. regulators into the potential hazards of certain plastic additives so far have not suggested that Congress should pass legislation to outlaw the chemicals, as governments in other countries have done, officials told a U.S. Senate subcommittee on Wednesday.
The European Commission is looking to update and simplify its legislation regulating the medical device industry and is seeking stakeholder input on the socio-economic impact of any proposed changes.
E.I. du Pont de Nemours & Co. submitted a report to the New Jersey Department of Environmental Protection this week, confirming that chemical residues feared to be carcinogenic have turned up in the groundwater near its Deepwater, N.J., facility at 35 times the alert level set by the state last year.
In the wake of the U.S. Food and Drug Administration's backlash against bioidentical hormone replacement drugs, lawmakers introduced a resolution Tuesday opposing the agency's policy restricting women's access to the products.